Critical analysis of the antinuclear antibody test as tool in clinical practice;Análise crítica do teste de anticorpos antinúcleo (FAN) na prática clínica

Revista Brasileira de Reumatologia

Volumn 47, Issue 4, 2007, Pages 265-275

  Dellavance, Alessandra ^a,b   Leser, Paulo Guilherme ^b   Andrade, Luís Eduardo Coelho ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fleury   (Brazil)

Author keywords

Antinuclear antibodies; Autoantibodies; Autoimmune diseases; HEp 2 cells

Indexed keywords

ANTINUCLEAR ANTIBODY;

ANTIBODY TITER; AUTOIMMUNE DISEASE; BRAZIL; CLINICAL PRACTICE; CLINICAL PROTOCOL; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOFLUORESCENCE TEST; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 51449103018     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0482-50042007000400005     Document Type: Review

References (40)

1. Hargraves M, Richmond M, Morton R. Presentation of two bone marrow elements: the "tart" cell or LE cell. Mayo Clin Proc 23: 25-8, 1948.
2. Tan EM, Cohen AS, Fries JF, et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-7, 1982.
3. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40: 1725, 1997.
4. Keren DF: Antinuclear antibody testing. Clin Lab Med 22(2): 447-74, 2002.
5. Coons AH, Kaplan MH: Localization of antigen in tissue cells II: improvements is a method for the detection of antigen by means of fluorescent antibody. J Exp Med 91: 1-13, 1950.
6. Gonzales C, Garcia-Berrocal B, Herraes O, Navajo JA, Gonzales-Buitrago JM: Anti-nucleosome, anti-chromatin, anti-dsDNA ans anti-histone antibody reactivity in systemic lupus erythematosus. Clin Chem Lab Med 42: 266-72, 2004.
7. Szanto A, Szodoray P, Kiss E, Kapitany A, Szegedi G, Zeher M: Clinical, serologic, and genetic profiles of patients with associated Sjogren's syndrome and systemic lupus erythematosus. Hum Immunol 67: 924-30, 2006.
8. Migliorini P, Baldini C, Rocchi V, Bombardieri S: Anti-Sm ans anti-RNP antibodies. Autoimmunity 38: 47-54, 2005.
9. Reimer G, Steen VD, Penning CA, Medsger TA Jr, Tan EM: Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 31:525-32, 1988.
10. Anderson JR, Gray KG, Beck JS, Buchanan WU, McElhinney AJ: Precipitating antibodies in the connective tissue diseases. Ann Rheum Dis 21: 360-9, 1962.
11. Aarden LA, Lakmaker F, de Groot ER, Swaak AJ, Feltkamp TE: Detection of antibodies to DNA by radioimmunoassay and immunofluorescence. Scand J Rheumatol Suppl (11): 12-9, 1975.
12. Andrade LEC: Como valorizar os resultados de teste de FAN (anticorpos antinúcleo) e suas diferentes metodotogias. Sinopses emn Reumatologia 4: 3-9, 2002.
13. Silva NP, Andrade LEC, Frangioni RZ, Silva RM, Sato EI, Leser PG: Desenvolvimento de ensaio imunoenzimático (ELISA) para detecção de anticorpos anti-DNA nativo usando DNA de Crithidia luciliae como substrato. Rev Bras Reumatol 35: 183-8, 1995.
14. Benito-Garcia E, Schur PH, Lahita R and The American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines: Guidelines for Immunologic Laboratory Testing in the Rheumatic Diseases: anti-Sm and anti-RNP antibody tests. Arthritis Rheum 51: 1030-44, 2004.
15. Harmon CE, Deng J-S, Peebles CL: The importance of tissue substrate in the SS-A/Ro antigen-antibody system. Arthritis Rheum 27: 166-73, 1984.
16. Beyne-Rauzy O, Thebault S, Adoue D, Fortenfant F: Anti-PCNA antibodies: prevalence and predictive value. Joint Bone Spine 72: 432-5, 2005.
17. Forslid J, Heigl Z, Jonsson J, Scheynius A: The prevalence of antinuclear in healthy young persons and adults, comparing rat liver tissue sections with HEp-2 cells as antigen substrate. Clin Exp Rheumatol 12: 137-41, 1994.
18. Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ: Antinuclear, anticytoplasmic, and anti-Sjögren's syndrome antigen A (SS-A/Ro) antibodies in famale blood donors. Clin Immunol Immunopathol. 36: 120-8, 1985.
19. a ed. Porto Alegre: Artmed, 2002. pp. 312-56.
20. Rokeach IA, Hoch SO: B-cell epitopes of Sm autoantigens. Mol Biol Reports 16: 165-74, 1992.
21. Migliorini P, Baldini C, Rocchi V, Bombardieri S: Anti-Sm and anti-RNP antibodies. Autoimmunity 38: 47-54, 2005.
22. Andrade LE, Chan EY, Raska I, Peebles CL, Roos G, Tan EM: Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80 coilin. J Exp Med 173: 1407-19, 1991.
23. Cimolai N, Mah D, Roland E: Anticentriolar autoantibodies in children with central nervous system manifestations of Mycoplasma pneumoniae infection. J Neurol Neurosurg Psychiatry 57: 638-9, 1994.
24. Leser PG, Dellavance A, Barbosa SH, et al.: Distinctive features of antinuclear antibodies observed in health and in subjects with autoimmune rheumatic diseases. In: Conrad K, Bachmann MP, Chan EKL, Fritzler MJ, Humbel RL, Sack U, Shoenfeld Y, eds. (org.). From animal models to human genetics: research on the induction and pathogenicity of autoantibodies. Dresden: Pabst Science Publishers pp. 493-510, 2004.
25. Goto N, Sugiura Y, Ogawa Y, et al.: Anti-p80 coilin autoantibodies react with a conserved epitope and are associated with anti-DSF70/LEDGF autoantibodies. J Autoimmun 26(1): 42-51, 2006.
26. Laurino CFC, Fritzler MJ, Mortara RA, Silva NP, Almeida IC, Andrade LEC: Human autoantibodies to diacyl-phosphatidylethanolamine recognize a specific set of discrete cytoplasmic domains. Clin Exp Immunol 143: 572-84, 2006.
27. Dellavance A, Viana VS, Leon EP, Bonfa ES, Andrade LE, Leser PG: The clinical spectrum of antinuclear antibodies associated with the nuclear dense fine speckled immunofluorescence pattern. J Rheumatol 32: 2144-9, 2005.
28. Shinohara T, Singh DP, Fatma N: LEDGF, a survival factor, activates stress-related genes. Prog Retin Eye Res 21: 341-58, 2002.
29. Watanabe A, Kodera M, Sugiura Y, Usuda T, Tan EM, Takasaki Y: Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheum 50: 892-900, 2004.
30. Fathi M, Dastmalchi M, Rasmussen E, Lundberg IF, Tornling G: Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 63: 297-301, 2004.
31. Ho KT, Reveille JD: The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 5: 80-93, 2003.
32. Tan EM, Feltkamp TE, Smolen JS, et al.: Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 40: 1601-11, 1997.
33. Dellavance A, Gabriel A, Cintra AFU, et al.: II Consenso Brasileiro de Fator Antinuclear em Células HEp-2. Definições para padronização da pesquisa contra constituintes do núcleo, nucléolo, citoplasma e aparelho mitótico e suas associações clinicas. Rev Bras Reumatol 43: 129-40, 2003.
34. Fernandez SAV, Lobo AZC, Oliveira ZNPO, Fukumori LMI, Perigo AM, Rivitti EA: Prevalence of antinuclear autoantibodies in the serum of normal blood donors. Rev Hosp Clin Fac Med S. Paulo 58: 315-9, 2003.
35. Santos LM, Moreira KECS, Rodrigues SH, Alamada Filho CM, Ramos LR, Andrade LEC: Prevalência e valor prognóstico de anticorpos antinucleares em indivíduos isodos. Rev Bras Reumatol 37: 323-8, 1997.
36. Hilario MO, Len CA, Roja SC, Terreri MT, Almeida G, Andrade LE: Frequency of antinuclear antibodies in healthy children and adolescents. Chn Pediatr 43: 637-42, 2004.
37. Lacroix-Desmazes S, Kaveri SV, Mouthon L, et al.: Self-reactive antibodies (natural autoandbodies) in healthy individuals. J Immunol Methods 216: 117-37, 1998.
38. Inokuchi T, Takiuchi H, Moriwaki Y, et al.: Retroperitoneal ancient schwannoma presenting as an adrenal incidentaloma: CT and MR findings. Magn Reson Imaging 24: 1389-93, 2006.
39. Massabki PS, Acceturi C, Nishie IA, Silva NP, Sato EI, Andrade LEC: Clinical implications of autoantibodies in HIV infection. AIDS 11: 1845-50, 1997.
40. Arbuckle MR, McClain MT, Rubertone MV, et al.: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349: 1526-33, 2003.